The new test aims to provide parents clarity on whether the latest sickness spreading through their house is Covid, the flu or something else entirely.
? From deciding whether to quarantine or head to the doctor or what medicine you should pick up, a lot is often riding on just what bug your kid might be carrying.
In hopes of clearing up the confusion without having to head to the doctor, the Food and Drug Administration The new test is manufactured by Lucira , and is the first over-the-counter test approved to check for Influenza A and B as well as COVID-19 in adults and children aged 2 and up. All you need to do is to take a nasal swab similar to Covid testing and you’ll get an easy-to-read electronic result in just 30 minutes, letting you know if your kid has Covid, the flu or neither.
The test hasn’t been made available to the public yet, but when released, parents will be able to pick up a test without a prescription at their local drug store or on Lucira’s website. Lucira hasn’t confirmed the price point for the combination test yet, but parents can most likely expect it to be around theirOf course, no test is 100 percent accurate, and there is a risk of false positives and false negatives.
While this at-home test might not replace the need for every doctor’s visit, it does make it easier for parents to make informed decisions and take charge of their family’s health. Until more combination tests are made available learn some of the tell-tale signs ofPlease note: The Bump and the materials and information it contains are not intended to, and do not constitute, medical or other health advice or diagnosis and should not be used as such.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Lire la suite »
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Lire la suite »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Lire la suite »
FDA approves nasal spray for migraines that may relieve symptoms within 30 minutesTh FDA approved Zavegepant, sold under the brand name Zavzpret, after studies showed it more effective than a placebo at treating migraine symptoms within 30 minutes and up to 48 hours later. FDA approves migraine nasal spray that works in minutes
Lire la suite »
US FDA approves Pfizer's nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Lire la suite »
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | CNNThe FDA has approved a new nasal spray as a rapid treatment for migraine pain in adults. The spray may relieve pain and other migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer says.
Lire la suite »